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A Distinct DNA-Methylation Boundary in the
50- Upstream Sequence of the FMR1 Promoter Binds
Nuclear Proteins and Is Lost in Fragile X Syndrome
Anja Naumann,1 Norbert Hochstein,1,4 Stefanie Weber,1 Ellen Fanning,2 and Walter Doerﬂer1,3,*
We have discovered a distinct DNA-methylation boundary at a site between 650 and 800 nucleotides upstream of the CGG repeat in the
ﬁrst exon of the human FMR1 gene. This boundary, identiﬁed by bisulﬁte sequencing, is present in all human cell lines and cell types,
irrespective of age, gender, and developmental stage. The same boundary is found also in different mouse tissues, although sequence
homology between human and mouse in this region is only 46.7%. This boundary sequence, in both the unmethylated and the
CpG-methylated modes, binds speciﬁcally to nuclear proteins from human cells. We interpret this boundary as carrying a speciﬁc chro-
matin structure that delineates a hypermethylated area in the genome from the unmethylated FMR1 promoter and protecting it from the
spreading of DNAmethylation. In individuals with the fragile X syndrome (FRAXA), the methylation boundary is lost; methylation has
penetrated into the FMR1 promoter and inactivated the FMR1 gene. In one FRAXA genome, the upstream terminus of the methylation
boundary region exhibits decreasedmethylation as compared to that of healthy individuals. This ﬁnding suggests changes in nucleotide
sequence and chromatin structure in the boundary region of this FRAXA individual. In the completely de novo methylated FMR1
promoter, there are isolated unmethylated CpG dinucleotides that are, however, not found when the FMR1 promoter and upstream
sequences are methylated in vitro with the bacterial M-SssI DNA methyltransferase. They may arise during de novo methylation only
in DNA that is organized in chromatin and be due to the binding of speciﬁc proteins.Introduction
Epigenetic mechanisms have assumed an important role in
molecular biology and medicine.1,2 Much of the work in
epigenetics is based on evidence linking sequence-speciﬁc
modiﬁcation of DNA by 5-methyldeoxy-cytidine (5-mC)3–6
and of H3 and H4 histones by acetylation and methyla-
tion7–9 to long-term gene silencing. Mammalian genomes
carry unique imprints of patterns of DNA and histone
modiﬁcations that can be cell-type speciﬁc and, in some
instances, interindividually conserved.10,11
The fragile X syndrome (FRAXA, [MIM 300624]) is char-
acterized by a fragile chromosomal site at Xq27.3, mental
retardation, attention deﬁcit/hyperactivity disorder, mac-
roorchidism after puberty, plus facial and skeletal dysmor-
phisms. At the molecular level, the expansion of a CGG
repeat located in the 50-untranslated region (UTR) of the
ﬁrst exon of the FMR1 (fragile X mental retardation) gene
[MIM 309550] and the hypermethylation of its promoter
region inactivate the FMR1 gene early in human develop-
ment.12–19 Inactivation or mutations of the FMR1 gene
and lack of its gene product during development lead to
this syndrome.12–19 However, in rare cases, full ampliﬁca-
tion of the CGG repeat in the absence of FMR1 promoter
methylation does not result in the FRAXA syndrome.20,21
Thecause for the instabilityof theCGGrepeatswithexpan-
sions to < 200 repeats (premutations) or > 200 repeats (full
mutations) is unknown. The presence of stable secondary606 The American Journal of Human Genetics 85, 606–616, NovembDNA structures as hairpins, triplex, and quadruplex DNA in
the repeat have been discussed as possible problems in the
normal replication, repair, or recombination reactions of
this DNA segment.22 Moreover, properties of the replication
fork, repeat length, and CpG methylation are thought to
affect repeat stability.23 Furthermore, the presence of an
origin of DNA replication in the vicinity of the repeat might
contribute to its instability.24–26
Previous analyses of DNA methylation in the FMR1
promoter were limited to a few methylation-sensitive
restriction sites18,19 or to bisulﬁte sequencing in a small
segment of the promoter.27,28 The present study provides
detailed analyses, previously not available, of the methyla-
tion proﬁle in a 5500 base pair (bp) segment of the FMR1
promoter and 50- upstream sequences in DNA from
numerous human cell lines, from normal primary human
cells from different tissues, and from FRAXA individuals.
The ﬁnding of a distinct zone of transition between meth-
ylated and unmethylated sequences in the 50-upstream
region of the FMR1 gene has not, to our knowledge, been
previously reported and has signiﬁcance to explain how
the CGG repeat can expand in close vicinity to an origin
of DNA replication. The methylation boundary is obliter-
ated and altered in DNA from FRAXA individuals. The
border sequences, both methylated and unmethylated,
are capable of binding speciﬁcally to nuclear proteins. A
distinct boundary is also observed in the equivalent DNA
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the nucleotide sequences of human and mouse are only
46.7% identical in the 50-upstream segment of the FMR1
gene.
Material and Methods
Source of DNA Samples
Because patterns of DNA methylation can differ from cell type to
cell type, we analyzed DNA samples from different primary
human adult and fetal cell types, from male and female individ-
uals, and from several human cell lines (Table S1, available online).
Mouse DNA from different tissues was also studied for documenta-
tion of the conservation of this DNA-methylation boundary at
this site across mammalian species (Table S1). Cell lines were prop-
agated in culture by standard procedures with the use of Dulbec-
co’s modiﬁed Eagle’s medium, 10% fetal bovine serum, and a 5%
CO2, 95% air atmosphere at 37
C. Human peripheral bloodmono-
nuclear cells (PBMCs) were puriﬁed by Ficoll (Biochrome) gradient
centrifugation.
Extraction of DNA
DNA from cultured cells or from PBMCs was isolated by the
Na-perchlorate-chloroform method.29 Several DNA samples were
obtained from commercial suppliers (Table S1). The quantity
and purity of all DNA preparations was ascertained by absorbance
measurements at 260 and 280 nm. Only DNA samples with a 260/
280 absorbance ratio of > 1.8 were used for further analyses.
Bisulﬁte Genomic Sequencing
For bisulﬁte genomic sequencing,30,31 500 ng of DNA was con-
verted in a total volume of 20 ml of RNase-free H2O with the Epi-
Tect Bisulﬁte Kit (QIAGEN, Hilden, Germany), with the use of
several alternating denaturation and bisulﬁte conversion steps.
The bisulﬁte conversion of the DNA was performed in a thermal
cycler under the following conditions: 99C for 5 min, 60C for
25 min, 99C for 5 min, 60C for 85 min, 99C for 5 min, 60C
for 175 min. By repeated 99C cycling, the EpiTect protocol
secures the maintenance of DNA denaturation during bisulﬁte
treatment, which is essential for complete C-to-T conversion.
The converted single-stranded DNA was bound to the membrane
of an EpiTect spin column without the use of carrier RNA. The
DNA was eluted in 40 ml elution buffer and stored at 20C. In
early experiments in this study, the bisulﬁte-sequencing method
was performed as described elsewhere.32 Nucleotide sequences
were routinely determined in the service facility of the Institute
for Human Genetics, Erlangen University Medical School.
Primers Used in Bisulﬁte-Sequencing Experiments
Table S2 lists primer sequences and their positions in the 50-
upstream and promoter regions of the FMR1 gene, in both the
human and mouse genomes.
Validation of the FMR1 Bisulﬁte-Sequencing Method
The reliability of the EpiTect protocol was assessed by applying it
to the analysis of commercially obtained human DNA (Figures
S1D and S1E) or of the plasmid-cloned25 FMR1 promoter sequence
(Figures S1F–S1H). Unmethylated DNA (Figures S1D and S1F) and
M.Sss I-premethylated DNA with all CpG dinucleotides methyl-
ated (Figures S1E and S1G) were found as anticipated. In a 1:1
mixture (Figure S1H), unmethylated and M.Sss I-premethylatedThe AmericaDNA molecules were represented in the expected ratio (Fig-
ure S1H). An additional precaution was applied, in that sequences
in clones with incomplete C-to-U (T) conversion products were
not included in the analyses.
Electrophoretic Mobility Shift Assays
For this series of experiments, protocols and reagents from Roche
(Mannheim, Germany) were employed.
Preparation of Nuclear Extracts from Human
HCT116 Cells
HCT116 cells were grown to conﬂuence in 75 cm2 plastic ﬂasks.
Nuclear extracts were prepared by resuspending the extensively
washed cells in hypotonic buffer (10 mM 4-(2-hydroxyethyl)-1-
piperazine-ethanesulfonic acid [HEPES], pH 7.9, 1.5 mM MgCl2,
10 mM KCl, 0.2 mM phenylmethylsulfonyl ﬂuoride [PMSF],
0.5 mM dithiothreitol [DTT]) and by allowing the cells to swell on
ice for 10 min. Cell membranes were broken in a Dounce homog-
enizer by ten strokes with a type B pestle. Nuclei were collected by
centrifugation and incubated for 1 hr at 4C in the same buffer
adjusted to 0.26 M KCl. The nuclear extract was subsequently
dialyzed at 4C against 20 mM HEPES, pH 7.9, 10% glycerol,
0.1 M KCl, 0.2 mM ethylenediamine tetraacetate (EDTA), 0.2 mM
PMSF, 0.5 mM DTT (binding buffer).
Labeling of DNA Probes
PCR was used for generating the 630 bp sequence spanning the
methylation-boundary fragment (red bar in Figure 1C) that was di-
goxygenin (DIG)-labeled or was left unlabeled in competition
experiments as described. In some experiments, all CpG dinucleo-
tides in a 630 bp sequence from the same region were in vitro pre-
methylated in a 5 hr reactionwith theM.Sss IDNAmethyltransfer-
ase (New England Biolabs). Complete methylation was conﬁrmed
by failure of methylation-sensitive restriction endonucleases to
cleave the premethylatedDNA fragment. For protein-binding reac-
tions, DNA fragments were digoxygenin labeled as recommended
by the manufacturer (Roche, Mannheim, Germany). In brief, 3.85
pmol of the DNA fragment was incubated at 37C for 15 min in
labeling buffer containing 5 mM CoCl2, 0.05 mM digoxygenin-
ddUTP, and 400 units of DNA terminal transferase. The reaction
was stopped in 0.2MEDTA anddiluted inH2O to 0.155 pmolDNA.
DNA-Protein Binding Reaction and Analyses of
Complexes by Electrophoretic Mobility Shift Assays
In a total volume of 20 ml binding buffer, 1 mg of poly [d(I-C)],
0.1 mg poly L-lysine, 0.2 ng DIG-labeled DNA fragment, and
2.64 mg protein from nuclear extracts were incubated for 15 min
at 37C. In competition reactions, a > 2000-fold excess of unla-
beled DNA fragments from different sources was added. Reaction
products were analyzed by electrophoresis in a precast 6% poly-
acrylamide retardation gel (NOVEX) in 0.53 TBE buffer for 3 hr
at 80 V, 10 mA. TBE buffer is 89 mM each of Tris and boric acid,
2 mM EDTA, pH 8.0. After electrophoresis, the reaction products
were transferred by electroblotting to a positively charged nylon
membrane with 0.53 TBE for 60 min at 30 V, 150 mA. The DNA
fragments were cross-linked to the membrane by baking for
30 min at 120C. Subsequently, the membranes were washed,
incubated for 30 min each in blocking buffer, and diluted in
anti-digoxygenin-AP conjugate, followed by a 5 min incubation
in detection buffer. Finally, 0.1 mg CSPD per ml working solution
(Roche) was added and incubation was continued for 5 min atn Journal of Human Genetics 85, 606–616, November 13, 2009 607
25C. The damp membrane was then sealed and incubated for 10
min at 37C for enhancement of the the CSPD chemiluminescent
reaction. The membrane was subsequently exposed to an imaging
device (charge-coupled device [CCD] camera, Fuji-LAS-1000).
Results
Sequence Characteristics andMultiple Genetic Signals
in the FMR1 Promoter and Its 50- Upstream Region
The 50-upstream region of the FMR1 gene (Xq27.3) is close
to the functionally relevant CGG repeat and is character-
ized by a number of important genetic signals (Figure S1C,
Figure 1C):
(1) The CGG repeat lies in the 50-UTR of the FMR1
gene’s ﬁrst exon. This repeat is expanded in FRAXA
individuals and is then devoid of the stabilizing
interspersed AGG trinucleotides.33
(2) The FMR1 promoter and the initiation site for RNA
transcription are located immediately upstream of
the CGG repeat. The promoter, aside from a nonca-
nonical TTACA signal,34 lacks a typical TATAA box
Figure 1. Methylation Profiles in the FMR1 Promoter and 50-Upstream Segment in the Human Cell Line HCT116 and in Primary
Human Fibroblasts
(A) Ideogram of the human X chromosome.
(B) Partial map shows the ﬁrst ten exons (vertical bars) and introns of the FMR1 gene plus the upstream genome segment including the
CGG repeat.
(C) Map of the 50-upstream region of the FMR1 gene. The graph presents all CpG dinucleotides (1 to 104) in the region: The arrow indi-
cates the start site of transcription. The promoter and an origin of DNA replication are also indicated. Nucleotide numbering in this and
the following graphswas adapted from the NCBI nucleotide nomenclature: NC_000023:146,786,201–146,840,303H. sapiens FMR1 gene
region (nucleotide numbers on the human X ¼ 23rd chromosome). The boundary between unmethylated and methylated CpG dinu-
cleotides is marked by the symbolsB and d, respectively, and is designated by a red bar.
(D) In HCT116 DNA, both strands (upper and lower panels) were sequenced with bisulﬁte between CpG pairs 20 and 83. Bisulﬁte
sequencing in one strand was extended to CpG pair 104 (lower panel). ,, unmethylated CpGs; -, methylated CpGs.
(E) In primary human foreskin ﬁbroblasts, DNA was sequenced with bisulﬁte between CpG pairs 20 and 104.
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but contains, in a region of about 1 kb upstream
from the site of transcriptional initiation, multiple
SpI sites (MIM 189906) and binding motifs for AP2
(MIM 107580), a-PAL/NRF1 (MIM 600879), and
myc35 (MIM 190080).
(3) An origin of DNA replication lies about 300 to 450
nucleotides upstream of the transcriptional initia-
tion site.24–26
(4) Between map position 15,060 and a site about 5500
nucleotides 50- upstream of the CGG repeat, there
are 104 CpG dinucleotides (Figure 1C), among them
several very closely spaced methylation-sensitive
restriction sites.
(5) A boundary between completely methylated and
essentially unmethylated CpG dinucleotides in
normal individuals has been identiﬁed in this study.
This methylation boundary is lost and might be
altered in FRAXA patients.
Methylation Proﬁle of the Region
In the maps in most ﬁgures, CpG dinucleotides in the
genome segment investigated are numbered from position
1, closest to (but not within) the CGG repeat, to position
104,mostdistant from it. FromCpGposition104upstream,
there are very few CpG dinucleotides. Becausemethylation
patterns can differ from one human cell type or line to
another,10 we analyzed DNA samples from a number of
different cell lines and a variety of human cells and tissues,
from fetal, adult, male, and female sources (Table S1).
In DNA from the human colorectal carcinoma cell line
HCT116 from a male individual without repeat expansion
(n ¼ 30),25 one DNA strand was sequenced between CpG
dinucleotides 20 and 83, and the opposite strand was
sequenced between CpGs 20 and 104 in individual clones
after bisulﬁte treatment (upper and lower panels in
Figure 1D, respectively). The DNA-methylation boundary
was found at CpG pairs 65 and 66 (upper and lower panels
in Figure 1D) about 650 nucleotides upstream of the CGG
repeat. The results were essentially identical, regardless of
whether the EpiTect method or a protocol used in earlier
studies27,32 was applied (data not shown). In DNA from
primary foreskin ﬁbroblasts, only one DNA strand was
sequenced between CpG dinucleotide positions 20 to
104, and the DNA-methylation border was found in the
region between CpG pairs 66 and 70 (Figure 1E). In the
region located further upstream, between CpG dinucleo-
tides 70 and 104, most CpGs were methylated (Figure 1E).
DNA samples from PBMCs of two male (Figures 2A and
2B) and two female (Figures 2C and 2D) donors were
analyzed in only one strand between CpG dinucleotide
positions 20 and 83. In twomale DNA samples, the distinct
border between the methylated and unmethylated regions
was located at CpG pair 70, and CpG pairs between posi-
tions 66 and 70 were methylated in only some of the chro-
mosomes analyzed. In the DNA from the female donors,
the methylation boundary was apparent at CpG pair 69
or 70 in about half of the DNA molecules. In the regionThe Americanbetween CpG pairs 20 and 68, some of the chromosomes
were methylated; others remained unmethylated, with
the ratio of methylated to unmethylated molecules ap-
proaching 1. This mosaic pattern probably reﬂected the
disparity of methylation levels on the two female X chro-
mosomes, one being highly methylated and the other
being unmethylated or hypomethylated (Figures 2C and
2D). The methylation boundary and a mosaic pattern
downstream were also observed in HeLa DNA (data not
shown).
In DNA from brain (Figure S2A) and liver (Figure S2B) of
male fetuses or from adult male brain, liver, and muscle
(Figures S2C–S2E, respectively), the DNA-methylation
divide was again found at the same or a similar location
as in the previously described DNA samples.
Mouse DNA
We also interrogated the DNA sequence in the equivalent
genome segment of the mouse genome (Figure 3A). The
methylation boundary was, as observed in human DNA,
conserved at CpG dinucleotide 57 in the mouse genome
in DNA from brain (Figure 3B) and liver (Figure 3C). Main-
tenance of this methylation boundary in the genome of
two different mammalian species strengthens the notion
that this site serves an important function. The concor-
dance of data from both species is remarkable also in that
sequence identity between the two species in the Fmr1
upstream region is only 46.7%.
In FRAXA Individuals, the Methylation Boundary Is
Lost and the FMR1 Promoter Is Heavily Methylated
Primary FRAXA lung ﬁbroblasts from a 22-week-old male
fetus (GM07072) and primary FRAXA male ﬁbroblasts
(GM05848) were commercially obtained (Table S1), and
their DNA was analyzed for its methylation status in the
50-upstream region of the FMR1 promoter. In both samples,
the DNA was completely methylated in almost all CpG
dinucleotides investigated between CpG positions 20 and
83 (GM07072) (Figure 4A) or 20 and 88 (GM05848) (Fig-
ure 4B), with the exception of a few isle-like CpG pairs
that had remained unmethylated in a background of
completely methylated DNA (Figures 4A and 4B). Also, in
14,451 DNA from PBMCs of a FRAXA patient, CpG pairs
20 to 83 were all methylated, except for some chromo-
somes around CpG position 30. The ﬁnding of a highly
methylated 50-upstream region in FRAXA individuals
corroborates published data from our and other laborato-
ries.27,28 In earlier studies,27 the methylation pattern in
the FMR1 50-upstream region of some FRAXA individuals
exhibited mosaic patterns.
In theDNAfrom theGM05848ﬁbroblasts and the14,451
PBMCs, the bisulﬁte analysis was extended upward to
include CpG dinucleotides 84 to 104. DNA methylation
in this far-upstreamsegmentof theboundarywasdecreased
in the ﬁbroblast sample GM05848 (Figure 4B) in compar-
ison to that in non-FRAXA individuals (Figures 1D and
1E). This decrease in methylation density between CpGJournal of Human Genetics 85, 606–616, November 13, 2009 609
Figure 2. Methylation Boundaries in the FMR1 Upstream Region from Male and Female PBMCs
(A and B) The two male individuals were 28 (A) and 73 (B) years of age.
(C and D) DNA samples from both female individuals revealed the methylation boundary in those molecules that were unmethylated
downstream, plus a methylation mosaic in the downstream region between CpG dinucleotides 20 and 70.
(E) FMR1 map as in Figure 1C.dinucleotides 89 to 104 in FRAXA DNA sample GM05848
might indicate alterations in the FRAXA boundary region.
A comparably marked decrease in DNA methylation in
CpG pairs 84 to 104 was not observed in DNA from the
14,451 PBMCs (Figure 4C).
The methylation pattern in the DNA from premutation
females (data not shown) was very similar to that of
normal female probands (Figures 2C and 2D). On at least
one chromosome of premutation carriers, the methylation
boundary in the 50-upstream region of the FMR1 gene was
preserved as in male non-FRAXA chromosomes.
Nuclear Proteins Bind Speciﬁcally to the Sequence
around the Methylation Boundary in Both the
Unmetylated and the Methylated States
Thenucleotide sequence around theboundary between the
fully methylated upstream and the unmethylated down-
streamDNAsegment in theFMR1upstreamregioncontains610 The American Journal of Human Genetics 85, 606–616, NovemCpG dinucleotides 57 to 75 (Figure 5A). Among these 19
CpG dinucleotides, seven are part of a 50-CGG-30 triplet.
Moreover, the following motifs are present in this DNA
segment: three 50-CCCTC-30 (GAGGG) motifs, ten 50-
CCTC-30 (GAGG) sequences, a 50-(CCAAA)6-30 repeat, and
one AluI site (50-AGCT-30) (Figure 5A). The methylation
boundary is located at or around CpG pair 66. We investi-
gated the capacity of this transition sequence to bind
nuclear proteins from human cells. Nuclear extracts from
human HCT116 cells were incubated with a 630 bp DIG-
labeledDNA fragment containing the region of themethyl-
ationboundary (red bar in Figure 1C). In someexperiments,
the 630 bp segment was premethylated with M.Sss I.
Protein-DNA complexes were visualized by electrophoresis
on native polyacrylamide gels. Several bands of shifted
DNA, presumably DNA-protein complexes, were observed
(Figure 5B, lane c, arrow and asterisks). The speciﬁcity of
these complexes was assessed in the following competitionber 13, 2009
experiments by the use of unlabeled 630 bpDNA fragments
as competitors in > 2000-fold excess:
(1) The unlabeled transition DNA fragment (Figure 5B,
lane d) competes all shifted DNA-protein complexes
(seven independent experiments).
(2) The unlabeled 595 bp DraI-RsaI fragment from the
b-lactamase (bla) gene (MIM 608440), of plasmid
pcDNA3.1 (þ) (Figure 5B, lane f), was used as a
nonspeciﬁc competitor and competes only the
slowly migrating bands (indicated by asterisks) but
not the complex close to the 1033 bp size marker
(Figure 5B, lane f).
(3) TheunlabeledM.Sss I-premethylated transitionDNA
fragment (Figure 5B, lane e) competes with probe
binding to all complexes, much like the unmethy-
lated fragment. In three independent experiments,
competition by the M.Sss I-premethylated probe
generated a DNA band of slightly higher molecular
mass than that of the unmethylated probe. This
control was performed because the transition frag-
ment is methylated from CpG pair 66 upstream in
DNA from all non-FRAXA human DNA sources.
The M.Sss I-premethylated and DIG-labeled transition
fragment was also shifted upon binding to proteins from
nuclear extracts (Figure 5B, lane i). The nuclear protein
binding to the M.Sss I-premethylated DIG-labeled transi-
tion fragment was competed by an excess of both unla-
beled methylated (Figure 5B, lane j) and unmethylated
(Figure 5B, lane k) transition DNA fragments.
On the basis of the competition patterns, we conclude
that nuclear proteins bind speciﬁcally to sequences in
the transition DNA fragment in both its unmethylated
and M.Sss I-premethylated forms. We cannot exclude the
possibility that there is a slight difference in the binding
of nuclear proteins to the unmethylated as compared to
the methylated boundary fragment. The slowly migrating
DNA complexes (marked by asterisks in Figure 5B, lanes c
and i), which are competed by the bla gene fragment,
appear to be nonspeciﬁc or less sequence-speciﬁc.
Discussion
DNA-Methylation Boundary
In a human genome segment of about 5500 bp in the
50-upstream segment of the FMR1 gene, we have identiﬁed
a distinct methylation boundary 650 to 800 nucleotides
and 65 to 70 CpG pairs upstream of the CGG repeat in
the human FMR1 gene. This boundary is deﬁned by an
upstream genome segment of about 4900 bp with
Figure 3. Methylation Boundaries in the Fmr1 Upstream Region in DNA from Adult Mouse Brain and Liver
(A) Ideogram and partial Fmr1 gene map of the mouse. Sequence comparisons between the human and mouse genomes in the Fmr1
upstream region were based on the published mouse genome sequence from the NCBI nucleotide depository for mouse chromosome
XA7.1: NC_000086:65,916,730-65,971,138 M. musculus Fmr1 gene region. The mouse Fmr1 map has been arranged similarly to the
map in Figure 1C.
(BandC)Themethylationboundary inthemouseFmr150-upstreamregionmapsatCpGdinucleotide57 inadultmousebrain (B)and liver (C).The American Journal of Human Genetics 85, 606–616, November 13, 2009 611
Figure 4. Loss of the Methylation Boundary in Fibroblasts and PBMCs from Male FRAXA Individuals
(A–C) In DNA from FRAXA individuals from commercially obtained ﬁbroblasts GM07072 (A) and GM05848 (B) or from PBMC sample
14,451 (C), the methylation border was absent andmethylation was observed throughout the promoter region downstream to the CGG
repeat, except for a few unmethylated CpG dinucleotides. In (A), a part of the opposite strandwas also sequenced. In (B) and (C), bisulﬁte
sequencing was extended upward to CpG dinucleotide 104.
(D) FMR1 map as in Figure 1C, except that all CpGs are indicated as methylated:C.completely methylated CpG dinucleotides and a shorter
downstream 670 bp stretch that is devoid of CpG methyl-
ation. The methylation boundary is often preceded on its
downstream side by a short genome segment that is char-
acterized by a methylation mosaic, with some of the chro-
mosomes methylated and others unmethylated, in a fuzzy
transition zone (Figures 1 and 2, Figure S2). This less
sharply structured region might be characteristic of chro-
matin ‘‘breathing’’ in the transition zone, with some of
the molecules fully methylated and others unmethylated.
The methylation boundary region is conserved in DNA
from both male and female human probands, regardless
of age, in human cell lines and in the mouse genome. In
samples from females, the 50-upstream and promoter
regions of the FMR1 gene contain DNA sequences from612 The American Journal of Human Genetics 85, 606–616, Novemboth X chromosomes. DNA from one X chromosome
carries a more heavily methylated DNA segment with
loss of the methylation boundary; DNA from the other X
allele, with its downstream region mainly unmethylated,
carries a methylation boundary very similar, if not iden-
tical, to that of male X chromosomes. This interpretation
is supported by the close 1:1 ratio of methylated to unme-
thylated molecules in the region between CpG dinucleo-
tides 20 to 69 or 70 in female DNA (Figures 2C and 2D).
The methylation border was present at the same location
in DNA from both fetal and adult tissues (Figure S2).
Occasionally, the occurrence of 5-mC nucleotides in
dinucleotide combinations other than CpGs have been
reported.36,37 In the present data, 5-mC has not been de-
tected in non-CpG dinucleotide combinations in aboutber 13, 2009
Figure 5. Specific Binding of Nuclear
Proteins from Human Cells to DNA
Sequences in the Boundary Region
(A) Nucleotide sequence in the transition
zone between fully methylated and unme-
thylated DNA in the FMR1 50-upstream
region. Several DNA motifs and a 50-
(CCAAA)6-3
0 repeat are indicated.
(B) Nuclear extracts from human HCT116
cells (2.64 mg of protein) were incubated
with the DIG-labeled 630 bp DNA frag-
ment from the boundary region in the
FMR1 50-upstream genome segment as
indicated. The reaction products were
analyzed by electrophoretic mobility shift
assays. Lanes a, g, and l: Marker DNA lanes
with DIG-labeled DNA fragments of sizes
as marked. Lane b: DIG-labeled 630 bp
fragment incubated without the addition
of nuclear extracts; lane c shows the same
after incubation with nuclear extracts.
Lane d: conditions as in lane c, except
that a > 2000-fold excess of an unlabeled
630 bp fragment was added as speciﬁc
competitor. Lane e: conditions as in lane
c, except that a > 2000-fold excess of an
unlabeled M.Sss I-premethylated 630 bp
DNA fragment from the transition region
was used for competition. Lane f: condi-
tions as in lane d, except that the compet-
itor was a 595 bp DraI-RsaI fragment from
the bla gene of E. coli plasmid pcDNA3.1
(þ). In lanes h–k, anM.Sss I-premethylated
630 bp DNA fragment from the transition
region was used for binding or competi-
tion experiments. Competition experi-
ments were performed as indicated in the
graph. Electrophoretic mobility was
toward the bottom. After electrophoresis
in a precast 6% polyacrylamide gel, the
DNA bands were visualized as described
in Material and Methods.
In (B), thepresumablyunspeciﬁccomplexes
are designated by asterisks (*), the speciﬁc
ones by arrows.700 bp of the 50-upstream segment of the human FMR1
gene in HCT116 and GM07072 (FRAXA individual) DNAs.
In unrelated promoters in the human genome previously
analyzed in our laboratory (RET [MIM 164761], CGGBP1
[MIM 603363], genes of the erythrocyte membrane, e.g.,
MIM 605331), such a methylation boundary has not been
observed at a comparable distance from the site of transcrip-
tional initiation.38–40However, at the 50- end of aCpG island
of the glutathione S-transferase (GSTP1) gene (MIM 134660),
a 50-(ATAAA)19–24-30 repeat deﬁnes a distinct border between
a methylated and an unmethylated domain in several
different human tissues that express the GSTP1 gene. This
methylationboundary is locatedatCpGsite44.41 Inprostate
cancer (MIM 176807), this boundary is lost, the promoter
fully methylated, and the gene silenced.41 In the upstream
methylation boundary of the FMR1 gene, a 50-(ATAAA)-30
repeat is not present. In the FMR1 segment between CpG
dinucleotides 60 and 61, downstream of the actual
boundary, a 50-(CCAAA)6-30 repeat is located (Figure 5A).The AmericanMethylation Boundary at Equivalent Site
in the Mouse Genome
Bisulﬁte sequencing of the 50-upstream segment in the
mouse genome also reveals a methylation boundary at
the site equivalent to that in the human genome (Figure 3).
At the nucleotide sequence level, both genomes are only
46.7% identical in the 50-upstream region of the FMR1
gene. Conservation of the methylation boundary across
mammalian species, even in nucleotide sequences that
differ by > 50%, underscores its potential structural and
functional importance.
Loss of the Methylation Boundary in DNA from
FRAXA Individuals
In FRAXA males, the boundary is completely lost, and
almost all of the 88 CpG dinucleotides in the 2260 bp
fragment extending down to the CGG repeat are methyl-
ated (Figures 4A–4C). In the roughly 3300-bp-long
segment far upstream in the boundary encompassingJournal of Human Genetics 85, 606–616, November 13, 2009 613
CpG dinucleotides 89 to 104, the degree of DNA methyla-
tion seems to be lower, particularly in the ﬁbroblast sample
GMO5848. This ﬁndingmight indicate an alteration in the
structureof themethylationboundary inFRAXA individuals.
CpG dinucleotides 89 to 104 in DNA from PBMC sample
14,451, however, are heavily methylated (Figure 4C). The
methylation boundary in the FMR1 50-upstream region
possibly coincides with a speciﬁc chromatin structure
that, when destabilized, allowsmethylation to spread down-
stream, which eventually culminates in the complete
methylation of the FMR1 promoter, as well as FMR1 gene
silencing, as shown for the GM07072 and GM05848 FRAXA
ﬁbroblasts.25
Isolated Unmethylated CpG Dinucleotides
in De Novo Methylated DNA
In the DNA from FRAXA patients, even the completely de
novo methylated promoter and 50-upstream sequences of
the FMR1 gene contain isolated unmethylated CpGs (Fig-
ure 4). In the region around CpG 30, some of these isolated
unmethylated CpGs coincide with transcription factor
binding sites (USF1 and USF2 orNRF1).28,42 Similar isolated
unmethylatedCpGs occur in the almost completely, also de
novo, methylated adenovirus type 12 genome in a trans-
formed hamster cell line that has been maintained in
culture for several decades.32 Thus, mammalian and inte-
grated viral genome segments of quite different derivations
that are characterized by a high degree of de novo CpG
methylation harbor one or several unmethylated CpG
dinucleotides, which might be typical of de novo methyl-
ated DNA. Comparable isolated unmethylated CpGs are
not apparent in de novo premethylated FMR1 DNA when
the bacterial M.Sss I has been used (Figures S1E S1G, and
S1H). Hence, these isolated unmethylated CpGs seem to
arise only during de novo methylation in living cells and
organisms, but not during in vitromethylation by bacterial
M.Sss I,possibly because a speciﬁc chromatin structure and/
or protein binding in intact mammalian chromosomes
precludes de novo methylation at these speciﬁc sites.
Proteins Binding at the Boundary Sequence
in the Human FMR1 50- Upstream Region
Wepropose that the FMR1 region carrying themethylation
boundary is characterized by a speciﬁc chromatin structure
and serves to demarcate the human FMR1 andmouse Fmr1
promoter regions from interspersed 50-upstream-located
DNA sequences of as-yet-undetermined functions. This
boundary region resembles an insulator element.43 The
identiﬁcation of speciﬁc DNA-protein complexes between
the upstream FMR1 boundary sequence and nuclear
proteins from human cells might provide a clue as to how
this methylation boundary is maintained. It has been sug-
gested that binding sites for putative transcription factors
and for speciﬁc zinc ﬁnger proteins are overrepresented in
border regions of methylation.44 The FMR1 upstream
boundary region contains one AluI (50-AGCT-30) sequence
and several additional motifs described in Figure 5A.614 The American Journal of Human Genetics 85, 606–616, NovembDNA in the transition zone fromnon-FRAXA individuals
contains the methylated CpG dinucleotides 66 to 75 and
the unmethylated CpGs 57 to 65. When the entire transi-
tion sequence of 630 bp was reacted with nuclear proteins,
distinct DNA-protein complexes were observed (Figure 5B).
DNA-protein complexes of nearly identical sizes were
formed by the transition DNA fragment both in the unme-
thylated and the fully CpGM.Sss I-methylated modes. The
speciﬁcity of these complexes was supported by the results
of competition experiments. Both the unmethylated and
the methylated DNA fragments competed the binding of
nuclear proteins to very similar extents and eliminated
complex formation with the labeled methylated and
unmethylated probes, respectively (Figure 5B). A 595 bp
fragment from the plasmid b-lactamase gene, chosen as
unspeciﬁc competitor, eliminated the complexes of higher
molecular mass, but not the complex migrating close to
the 1033 bp size marker (Figure 5B, lane f). We therefore
consider this latter complex the one with the highest
degree of speciﬁcity. Alterations of chromatin structure at
this site of transition between unmethylated and fully
methylated genome segments, or the abrogation of a
higher-order chromatin structure at this site, might be
responsible for the loss of the methylation barrier and
lead to the extension of de novo methylation into the
FMR1 promoter that becomes silenced in response.25 The
less-complete methylation proﬁle in the far 50-upstream
region in ﬁbroblasts of one of the analyzed FRAXA cases
(Figure 4B) might be an indication of this destabilization.
Supplemental Data
Supplemental Data include two ﬁgures and two tables and can be
found with this article online at http://www.cell.com/AJHG/.
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